[ad_1] MaaT Pharma secures important funding in line with one of the goals under the Health Innovation 2030 Plan, the health component of ‘France 2030’, led by the Health Innovation…
Tag: MicrobiomeBased
Four Analyses of Data for REBYOTA™ (fecal microbiota, live – jslm), the First FDA-Approved Microbiome-Based Treatment for the Prevention of Recurrent C. difficile Infection, Presented at DDW 2023
[ad_1] This section is Partnership Content supplied The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients. Postmedia…